Clinical trials
Completed Myelodysplastic Syndromes trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 5 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 5 |
| 2021 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 53 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| Celgene | 5 |
| Children's Oncology Group | 5 |
| Astex Pharmaceuticals, Inc. | 3 |
| Kiadis Pharma | 3 |
| Pfizer | 3 |
| Mirati Therapeutics Inc. | 2 |
| NCIC Clinical Trials Group | 2 |
| AbbVie | 1 |
| Constellation Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 53 |
| Leukemia, Myeloid, Acute | 24 |
| Leukemia, Myelomonocytic, Chronic | 15 |
| Leukemia | 13 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 9 |
| Anemia, Refractory, with Excess of Blasts | 6 |
| Myeloproliferative Disorders | 6 |
| Hematologic Neoplasms | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Lymphoma | 5 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.